BFM
IMGN

Boothbay Fund Management’s Immunogen Inc IMGN Stock Holding History

Boothbay Fund Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70,394
Closed -$2.09M – 2056
2023
Q4 		$2.09M Sell
70,394
-16,592
-19% -$330K 0.05% 470
2023
Q3 		$1.38M Sell
86,986
-5,765
-6% -$95.9K 0.03% 630
2023
Q2 		$1.75M Buy
+92,751
New +$1.1M 0.04% 612
2020
Q3 		– Sell
-25,410
Closed -$117K – 1281
2020
Q2 		$117K Buy
25,410
+1,210
+5% +$5.15K 0.01% 864
2020
Q1 		$83K Buy
+24,200
New +$106K 0.01% 749
2019
Q3 		– Sell
-36,095
Closed -$78K – 941
2019
Q2 		$78K Buy
36,095
+6,725
+23% +$15.9K 0.01% 672
2019
Q1 		$80K Buy
+29,370
New +$127K 0.01% 670

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boothbay Fund Management's IMGN Position: Q1 2024 in Review

Boothbay Fund Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 70,394 shares — an estimated $2.09M sold.

Boothbay Fund Management first reported a position in IMGN in Q1 2019 and held it in 7 quarters. The position peaked at $2.09M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Boothbay Fund Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 70,394 Immunogen Inc shares in Q1 2024, an estimated $2.09M.
  • Boothbay Fund Management first reported a position in Immunogen Inc in Q1 2019 and held it in 7 quarters.
  • Boothbay Fund Management's Immunogen Inc position peaked at $2.09M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.